calpain/cathepsin inhibitors (HMR)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecalpain/cathepsin inhibitors (HMR)
Drug Alias NameMDL-104092MDL-104903MDL-105608MDL-103821MDL-104860 +[9] 
ClassificationSmall molecules
Mechanisms of ActionCalpain inhibitorsCathepsin B modulatorsNeuroprotectants
TargetsCathepsin BCalpain
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis Pharmaceuticals IncHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A